Back to search

University of York

Synthesis of Thiazoline Based Inhibitors for O-GlcNAcase

Abstract

dc:description.abstract

O-GlcNAcylation is a dynamic post-translational modification that regulates numerous cellular processes and is implicated in several diseases.1-13 This modification is reversed by O- GlcNAcase (OGA) a glycoside hydrolase from the family GH84. Due to the involvement of OGA in disease and the limited understanding of O-GlcNAcylation further understanding of the roles OGA plays are required. To facilitate greater understanding of OGA activity-based probes could play an important role as they selectively label active populations of the target enzyme. For the development of ABPs to start a covalent inhibitor must be found. Covalent binding between the inhibitor and the enzyme is a prerequisite for permanent labelling. Several OGA inhibitors exist, but none are capable of forming a covalent bond to the target enzyme. This thesis addresses the development of novel thiazoline-based OGA inhibitors that contain electrophilic warheads targeted against the catalytic base in OGA and a pocket bound cysteine residue. The research builds upon existing scaffolds such as Thiamet-G, aiming to explore structural analogues that exploit the catalytic mechanism of OGA and its active site configuration. Here, the synthesis and where relevant the biological evaluation of three distinct series of thiazoline-based inhibitors are shown. In Chapter I, efforts to synthesise covalent inhibitors based on epoxide-bearing glucose analogues were met with challenges in regioselectivity and synthetic accessibility. Chapter II details the design and synthesis of thiazoline derivatives bearing electrophilic warheads. These compounds demonstrated micromolar potency in vitro. In Chapter III, further analogues were synthesised containing chloro-, iodo- and bromo- acetic derived analogues of Thiamet-G which showed low nanomolar potency against OGA in vitro. 1. Emilyn U. Alejandro, et al., Cell Reports, 2015, 13, 2527-2538. 2. K. T. Jacobsen and K. Iverfeldt, Biochemical and Biophysical Research Communications, 2011, 404, 882-886. 3. Y. S. Chun, Y. Park, H. G. Oh, T.-W. Kim, H. O. Yang, M. K. Park and S. Chung, Journal of Alzheimer's Disease, 2015, 44, 261-275. 4. C. Kim, et al., Neurobiology of Aging, 2013, 34, 275-285. 5. S. A. Yuzwa, et al., Nature Chemical Biology, 2008, 4, 483-490. 6. P. Raman, I. Krukovets, T. E. Marinic, P. Bornstein and O. I. Stenina, Journal of Biological Chemistry, 2007, 282, 5704-5714. 7. I. G. Lunde, et al., Physiological Genomics, 2012, 44, 162-172. 8. M. V. Cannon, et al., EMBO Molecular Medicine, 2015, 7, 1229-1243. 9. J. S. G. Miguez, et al., Life Sciences, 2018, 209, 78-84. 10. Christina M. Ferrer, et al., Molecular Cell, 2014, 54, 820-831. 11. Y. Liu, et al., EMBO reports, 2023, 24, e56458. 12. Y. Liu, et al., Cell Death & Disease, 2018, 9, 485. 13. C. Wu, J. Li, L. Lu, M. Li, Y. Yuan and J. Li, Journal of Biological Chemistry, 2024, 300.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of York
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Robertson, Alexander
Advisors dc:contributor.advisor
  • Willems, Lianne
  • Davis, Gideon
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Robertson, Alexander. Synthesis of Thiazoline Based Inhibitors for O-GlcNAcase. doctoral thesis, University of York, 2025.